Medical Oncology

Papers
(The H4-Index of Medical Oncology is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)
ArticleCitations
Steps in metastasis: an updated review139
Cancer treatment during COVID-19 pandemic52
Exosomes and cancer: from molecular mechanisms to clinical applications48
An updated review of epidemiology, risk factors, and management of male breast cancer34
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review34
Strategies for having a more effective and less toxic CAR T-cell therapy for acute lymphoblastic leukemia31
Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?28
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors26
COVID-19 and cancer care: what do international guidelines say?25
Neuroendocrine breast carcinoma: a rare but challenging entity25
MicroRNAs and target molecules in bladder cancer24
Luteolin and cancer metastasis suppression: focus on the role of epithelial to mesenchymal transition20
Associated analysis of PER1/TUBB2B with endometrial cancer development caused by circadian rhythm disorders20
Cancer stem cells in colorectal cancer and the association with chemotherapy resistance19
Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells19
Cinnamaldehyde induces endogenous apoptosis of the prostate cancer-associated fibroblasts via interfering the Glutathione-associated mitochondria function19
Wee1 kinase inhibitor AZD1775 potentiates CD8+ T cell-dependent antitumour activity via dendritic cell activation following a single high dose of irradiation18
Identification of hub genes associated with obesity-induced hepatocellular carcinoma risk based on integrated bioinformatics analysis18
Acute myeloid leukemia sensitivity to metabolic inhibitors: glycolysis showed to be a better therapeutic target18
0.1046290397644